Life Sciences

Industries > Life Sciences > SEC Comment Letter Report

SEC Comment Letter Report

The life sciences industry is competitive, volatile, and constantly changing—three reasons the Securities and Exchange Commission (SEC) scrutinizes life sciences companies’ pre- and post-IPO filings.

Streamline your company’s filing process by reviewing our annual report, Under the Microscope: An Analysis of SEC Comment Letter Trends Among Middle-Market and Pre-IPO Life Sciences Companies. 

The in-depth report takes a look at SEC comment letter trends directed toward S-1, 10-K, 10-Q, and 20-F filings; comparisons to prior years; and implications for your middle market or pre-IPO life sciences company.

Current Reports

Historical Reports

More Resources

Stay current on evolving industry trends and standards—sign up to receive alerts, articles, and event notifications.

Primary Contact

Photo of Rich Croghan
Rich Croghan
Principal
(415) 677-8282

Baker Tilly US, LLP, Baker Tilly Advisory Group, LP and Moss Adams LLP and their affiliated entities operate under an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly Advisory Group, LP and its subsidiaries, and Baker Tilly US, LLP and its affiliated entities, trading as Baker Tilly, are members of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. Baker Tilly US, LLP and Moss Adams LLP are licensed CPA firms that provide assurance services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and consulting services to their clients and are not licensed CPA firms. ISO certification services offered through Moss Adams Certifications LLC. Investment advisory offered through either Moss Adams Wealth Advisors LLC or Baker Tilly Wealth Management, LLC.